CRI Worldwide, LLC - Lourdes Division — Willingboro, New Jersey

CRI Worldwide, LLC - Lourdes Division is a clinical research site located in Willingboro, New Jersey, United States 08046.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

CRI Worldwide, LLC - Lourdes Division has participated in 1 clinical trials.

Therapeutic areas: Major Depressive Disorder.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Willingboro

Browse all research sites in New Jersey · View every site in Willingboro

• CRI Worldwide, 1113 Hospital Dr. Suite 202,
• CRI Worldwide - Lourdes Hospital
• CRI Worldwide
• Research Site
• Pfizer Investigational Site
• GSK Investigational Site
• Alkermes Investigational Site
• Novartis Investigative Site
• Forest Investigative Site 002
• Clinical Site
• Lourdes Medical Associates
• Shionogi Research Site

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CRI Worldwide, LLC - Lourdes Division?

CRI Worldwide, LLC - Lourdes Division has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CRI Worldwide, LLC - Lourdes Division conducted?

CRI Worldwide, LLC - Lourdes Division has 1 clinical trials on record. Their work covers Major Depressive Disorder.

Is CRI Worldwide, LLC - Lourdes Division accredited by Crixeo Clinical Trials?

CRI Worldwide, LLC - Lourdes Division has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CRI Worldwide, LLC - Lourdes Division?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.